Company Profile Boehringer Ingelheim

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 15 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.  The company is known for many prescription medicines and also consumer health care products.  Boehringer Ingelheim is also on the forefront of researching, developing and manufacturing biopharmaceuticals.
In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment Prescription Medicines on research and development.
In Human Pharmaceuticals, the company operates  four major R&D sites and three smaller specialised sites worldwide, which focus on six major therapeutic areas:
- Respiratory diseases, cardiometabolic diseases, oncology, neurological diseases, immunology and infectious diseases.

For more information please visit
www.boehringer-ingelheim.com